12:00 – 12:30 Paz Boix Optimization of Accurate Breast Cancer Models for the Advanced Preclinical Evaluation of Polymer Therapeutics Polymer therapeutics-based approaches provide advantage over the “free” form of a given
12:00 – 12:30 Paz Boix
Optimization of Accurate Breast Cancer Models for the Advanced Preclinical Evaluation of Polymer Therapeutics Polymer therapeutics-based approaches provide advantage over the “free” form of a given drug, including enhanced passive tumor targeting, altered pharmacokinetics, and specific release of drugs at the tumor site thanks to the use of bioresponsive linkers. In vitro characterization of polymer therapeutics commonly employs traditional two-dimensional (2D) cell culture approaches that fail to fully recapitulate important in vivo tumor characteristics. Therefore, we developed optimized three-dimensional (3D) breast cancer culture systems growing in basement membrane matrix extract as a robust platform for the characterization of novel anti-cancer polymer therapeutics. We first established and optimized patient-derived breast cancer organoid and cell line-derived spheroid cultures and then confirmed the maintenance of breast cancer subtype-defining biomarkers. We next characterized the 2D and 3D models and encountered significant differences in metabolic profiles, the epithelial-to-mesenchymal transition, and the expression of breast cancer biomarkers linked to prognosis. We also compared specific drug release-triggering stimuli such as reactive oxygen species (ROS) and cathepsin B levels between breast cancer subtypes, which revealed that 3D cultures of MCF7, MDA-MB-453, and ZR75 breast cancer cell lines displayed significantly increased ROS levels compared to 2D, while cathepsin B levels tended to decrease in 3D ZR75 cultures when compared to 2D. Finally, we evaluated the internalization and lysosomal colocalization of the polyglutamic acid carrier in breast cancer spheroids and characterized the toxicity of a polymer-based combination conjugate carrying a curcuminoid and endocrine therapy both in 3D culture than in 2D culture, obtaining promising results. Our findings highlight the need to employ 3D culture conditions to generate robust characterization data for polymer therapeutics-based anti-cancer strategies. We now aim to apply our 3D models derived from cell lines and patient samples to evaluate both single-drug and combination polymer therapeutics in the hope that this platform will accelerate clinical translation.
12:30 – 13:00 Paco Ibáñez
Role of Extracellular Vesicles during ethanol induced neuroinflammation in adolescence Current evidence indicates that extracellular vesicles (EVs) participate in intercellular signaling and in the regulation and amplification of neuroinflammation. We have demonstrated that ethanol is able to induce an inflammatory immune response through the toll-like receptor 4 (TLR4) activation. But how ethanol alters EVs physiology is not well understood. In the first part of the study, we evaluated if ethanol, through TLR4 response, could change the release and inflammatory content of astrocyte-derived EVs, and whether these vesicles were capable to communicate with neurons and spread neuroinflammation. Previous results of the lab showed that the female brain is more vulnerable to the inflammatory effects of binge ethanol drinking in adolescence than the male brain, and these differences can be detected in plasma. Since EVs can cross the blood brain barrier and the EV miRNAs are highly stable in peripheral circulation, for the second part of the study we analyzed gender differences in the levels of several inflammatory-related miRNAs in plasma EVs derived from alcohol-intoxicated female and male adolescents and whether these miRNAs of EVs could be used as biomarkers of the neuroinflammation induced by ethanol in adolescence.
(Friday) 12:00 - 13:00
Centro de Investigación Príncipe Felipe
Eduardo Primo Yúfera, 3 Valencia Spain
Centro de Investigación Príncipe Felipe Eduardo Primo Yúfera, 3